Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro

被引：233

作者：

Fizazi, K. ^{[1
]}

Greco, F. A. ^{[2
]}

Pavlidis, N. ^{[3
]}

Daugaard, G. ^{[4
]}

Oien, K. ^{[5
]}

Pentheroudakis, G. ^{[3
]}

机构：

[1] Univ Paris 11, Inst Gustave Roussy, Dept Canc Med, Villejuif, France

[2] Centennial Med Ctr, Tennessee Oncol, Nashville, TN USA

[3] Univ Ioannina, Dept Med Oncol, GR-45110 Ioannina, Greece

[4] Copenhagen Univ Hosp, Rigshosp, Dept Oncol 5073, Copenhagen, Denmark

[5] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland

来源：

ANNALS OF ONCOLOGY | 2015年 / 26卷

关键词：

1ST-LINE TREATMENT; PRIMARY ORIGIN; PRIMARY CUP; CARCINOMA; TRIAL; VALIDATION; GEMCITABINE; METASTASES; CISPLATIN; STANDARD;

D O I：

10.1093/annonc/mdv305

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：V133 / V138

页数：6

共 32 条

[1] ANALYSIS OF A DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED TUMORS OF UNKNOWN ORIGIN [J].

ABBRUZZESE, JL ;

ABBRUZZESE, MC ;

LENZI, R ;

HESS, KR ;

RABER, MN .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :2094-2103

[2] Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002) [J].

Bugat, R ;

Bataillard, A ;

Lesimple, T ;

Voigt, JJ ;

Culine, S ;

Lortholary, A ;

Merrouche, Y ;

Ganem, G ;

Kaminsky, MC ;

Negrier, S ;

Perol, M ;

Laforêt, C ;

Bedossa, P ;

Bertrand, G ;

Coindre, JM ;

Fizazi, K .

BRITISH JOURNAL OF CANCER, 2003, 89 (Suppl 1) :S59-S66

[3] Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site:: Results of a randomized phase II study-trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01) [J].

Culine, S ;

Lortholary, A ;

Voigt, JJ ;

Bugat, R ;

Théodore, C ;

Priou, F ;

Kaminsky, MC ;

Lesimple, T ;

Pivot, X ;

Coudert, B ;

Douillar, JY ;

Merrouche, Y ;

Allouache, J ;

Goupil, A ;

Négrier, S ;

Viala, J ;

Petrow, P ;

Bouzy, J ;

Laplanche, A ;

Fizazi, K .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) :3479-3482

[4] Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site [J].

Culine, S ;

Kramar, A ;

Saghatchian, M ;

Bugat, R ;

Lesimple, T ;

Lortholary, A ;

Merrouche, Y ;

Laplanche, A ;

Fizazi, K .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (24) :4679-4683

[5] Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients [J].

Dykewicz, CA .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :139-144

[6] Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: Multiple-treatments meta-analysis [J].

Golfinopoulos, Vassilis ;

Pentheroudakis, George ;

Salanti, Georgia ;

Nearchou, Andreas D. ;

Ioannidis, John P. A. ;

Pavlidis, Nicholas .

CANCER TREATMENT REVIEWS, 2009, 35 (07) :570-573

[7] Molecular Profiling Diagnosis in Unknown Primary Cancer: Accuracy and Ability to Complement Standard Pathology [J].

Greco, F. Anthony ;

Lennington, Wayne J. ;

Spigel, David R. ;

Hainsworth, John D. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (11) :782-790

[8] Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial [J].

Gross-Goupil, M. ;

Fourcade, A. ;

Blot, E. ;

Penel, N. ;

Negrier, S. ;

Culine, S. ;

Chaigneau, L. ;

Lesimple, T. ;

Priou, F. ;

Lortholary, A. ;

Kaminsky, M. C. ;

Provencal, J. ;

Voog, E. ;

Bouzy, J. ;

Laplanche, A. ;

Fizazi, K. .

EUROPEAN JOURNAL OF CANCER, 2012, 48 (05) :721-727

[9] Identifying the Primary Site Using Gene Expression Profiling in Patients with Carcinoma of an Unknown Primary (CUP): A Feasibility Study from the GEFCAPI [J].

Gross-Goupil, Marine ;

Massard, Christophe ;

Lesimple, Thierry ;

Merrouche, Yacine ;

Blot, Emmanule ;

Loriot, Yohan ;

Mathieu, Marie C. ;

Fizazi, Karim .

ONKOLOGIE, 2012, 35 (1-2) :54-55

[10] Paclitaxel/Carboplatin With or Without Belinostat as Empiric First-Line Treatment for Patients With Carcinoma of Unknown Primary Site: A Randomized, Phase 2 Trial [J].

Hainsworth, John D. ;

Daugaard, Gedske ;

Lesimple, Thierry ;

Huebner, Gerdt ;

Greco, F. Anthony ;

Stahl, Michael J. ;

Bueschenfelde, Christian Meyer Zum ;

Allouache, Djelila ;

Penel, Nicolas ;

Knoblauch, Poul ;

Fizazi, Karim S. .

CANCER, 2015, 121 (10) :1654-1661

← 1 2 3 4 →